Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$459K Sell
3,020
-124
-4% -$19.6K 0.02% 471
2019
Q2
$481K Sell
3,144
-124
-4% -$18.9K 0.03% 488
2019
Q1
$524K Sell
3,268
-25
-0.8% -$3.88K 0.03% 464
2018
Q4
$508K Buy
3,293
+120
+4% +$18.7K 0.03% 454
2018
Q3
$477K Sell
3,173
-99
-3% -$14.1K 0.02% 487
2018
Q2
$443K Sell
3,272
-674
-17% -$83.2K 0.01% 513
2018
Q1
$525K Sell
3,946
-289
-7% -$38.8K 0.01% 489
2017
Q4
$630K Sell
4,235
-299
-7% -$40.7K 0.01% 460
2017
Q3
$598K Sell
4,534
-50
-1% -$6.72K 0.01% 451
2017
Q2
$611K Buy
4,584
+1
+0% +$135 0.01% 451
2017
Q1
$618K Sell
4,583
-799
-15% -$103K 0.01% 426
2016
Q4
$646K Sell
5,382
-2,054
-28% -$242K 0.02% 425
2016
Q3
$931K Sell
7,436
-188,924
-96% -$24.7M 0.02% 365
2016
Q2
$27.2M Buy
196,360
+24,501
+14% +$3.18M 0.68% 31
2016
Q1
$21.7M Buy
171,859
+166,867
+3,343% +$21.2M 0.53% 50
2015
Q4
$633K Sell
4,992
-1,125
-18% -$140K 0.01% 408
2015
Q3
$707K Buy
6,117
+1
+0% +$112 0.03% 444
2015
Q2
$636K Sell
6,116
-149
-2% -$16.1K 0.03% 399
2015
Q1
$692K Sell
6,265
-1,199
-16% -$130K 0.03% 368
2014
Q4
$778K Buy
7,464
+1,078
+17% +$108K 0.03% 288
2014
Q3
$613K Buy
6,386
+876
+16% +$79.2K 0.03% 320
2014
Q2
$504K Sell
5,510
-399
-7% -$35.7K 0.02% 352
2014
Q1
$520K Sell
5,909
-1,199
-17% -$105K 0.02% 334
2013
Q4
$659K Buy
7,108
+1
+0% +$90 0.03% 309
2013
Q3
$581K Sell
7,107
-299
-4% -$25.2K 0.03% 309
2013
Q2
$616K Buy
+7,406
New +$637K 0.03% 300

Other funds holding CLX

Boston Advisors's CLX Position: Q3 2019 in Review

Boston Advisors reduced its Clorox (CLX) stake by 3.9% in Q3 2019, selling an estimated $19.6K and leaving 3,020 shares worth $459K. The position accounts for 0.02% of the portfolio, ranked #471.

Boston Advisors first reported a position in CLX in Q2 2013 and has held it in 26 quarters since. The position peaked at $27.2M in Q2 2016. 979 funds tracked by Wall St. Rank hold CLX as of Q3 2019.

  • Boston Advisors held 3,020 shares of Clorox worth $459K as of Q3 2019.
  • Boston Advisors sold 124 Clorox shares in Q3 2019, an estimated $19.6K.
  • Clorox made up 0.02% of Boston Advisors's portfolio in Q3 2019, its #471 holding.
  • Boston Advisors first reported a position in Clorox in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Clorox position peaked at $27.2M in Q2 2016.
  • 979 funds tracked by Wall St. Rank held Clorox as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.